🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareAdolescent obesity: AAP guidelines and GLP-1 use in minors Page 2

Adolescent obesity: AAP guidelines and GLP-1 use in minors

PedsEndoPhilly Mon, Feb 23, 2026 at 8:38 AM 22 replies 811 viewsPage 2 of 5
SteveThurs
Member
523
2,345
Sep 2024
Wisconsin
Online
Feb 23, 2026 at 11:28 AM#6

Subscribing to this thread. Adolescent obesity AAP is exactly what I've been researching. 🙏

12 12MaxMetOK, MounjBrad, nick_newbie and 9 others
Reply Quote Save Share Report
claudia_zurich
Member
389
1,678
Jul 2024
Zurich, CH
Feb 23, 2026 at 11:45 AM#7

As a healthcare provider, I want to add some clinical context to this discussion on Adolescent obesity AAP guidelines and.

Building on what josh_phd_bmore said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 23, 2026 at 5:45 PM
41 8tammy_FL, Dr.LipidDallas, alex_tucson and 38 others
Reply Quote Save Share Report
mike_mealprep
Member
412
1,890
Jul 2024
Chicago, IL
Feb 23, 2026 at 12:02 PM#8

Reading this thread on Adolescent obesity AAP hits close to home. Night shift nurse — I started at 267 lbs and felt like I would tried everything.

13 months on tirz and I am a different person. Not just the 42 lbs lost — my energy, my mood, my relationship with food. All transformed.

If you are on the fence about Adolescent obesity — take the leap. It was the best health decision I have ever made. ❤️

Last edited: Feb 23, 2026 at 6:02 PM
3 4Dr.AddMedPHL, newstart_MO, mia_MS2
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
anna.melb_AU
Member
678
2,890
Apr 2024
Melbourne, AU
Feb 23, 2026 at 12:19 PM#9

CarlaRPh_TPA — that is really helpful context on Adolescent obesity AAP. Follow-up question: what labs did your doctor order to monitor this?

I am in a similar situation (just started) and trying to set realistic expectations.

Last edited: Feb 23, 2026 at 4:19 PM
32 20tammy_FL, Dr.LipidDallas, alex_tucson and 29 others
Reply Quote Save Share Report
GenomicsKate
Member
345
1,890
Oct 2024
Cambridge, MA
Feb 23, 2026 at 12:36 PM#10

To answer mike_mealprep's question specifically:

From a clinical standpoint, Adolescent obesity AAP is an area where we have good evidence.

The short answer: baseline labs + quarterly monitoring is the standard of care.

The longer answer involves understanding the mechanism of action at the receptor level, which I am happy to elaborate on if helpful.

5 7claudia_zurich, nancy_portland, rick_sfbay and 2 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register